Reply to Jin et al.: Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question

Am J Respir Crit Care Med. 2022 May 15;205(10):1251-1252. doi: 10.1164/rccm.202201-0081LE.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antihypertensive Agents* / therapeutic use
  • Epoprostenol* / analogs & derivatives
  • Epoprostenol* / therapeutic use
  • Humans

Substances

  • Antihypertensive Agents
  • Epoprostenol
  • treprostinil